Human Recombinant TACI (from E. coli)
Supplier: PEPROTECH INC.Total Ratings: 0
Avg. Ratings: 0.0 out of 5
TACI, a member of the TNF Receptor superfamily, is expressed in the small intestine, spleen, thymus, peripheral blood leukocytes, activated T cells, and resting B cells. TACI can bind to both APRIL and BAFF, stimulate the activation of transcription factors NF-κB and AP-1, and can mediate the calcineurin-dependent activation of NF-AT (nuclear-factor of activated T cells). TACI also plays a key role in the stimulation of B and T cell function. Soluble TACI inhibits APRIL-stimulated proliferation of primary B cells by blocking the binding of APRIL to the membrane-anchored TACI receptor. Recombinant Human TACI is a soluble 159 amino acid polypeptide (17.8 kDa) comprising the TNFR homologous, cysteine-rich extracellular domain of the TACI protein.
Ordering information: For research use only. Not for use in diagnostic or therapeutic procedures.
Learn more
About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...